104 results
Page 2 of 6
6-K
EX-99.1
x2f93i1gye19v q2fx7
1 Aug 22
Current report (foreign)
4:48pm
6-K
x7iw1qu3 vzy3f3xva
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-99.1
b4donw9rx1 bj6s
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
20-F/A
w834fh9al 7sf
3 Mar 22
Annual report (foreign) (amended)
6:57pm
SUPPL
8uj63ky1
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
5x0uddu0l1213c
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B5
7lbgmn7foo09 k1
8 Mar 21
Prospectus supplement for primary offering
5:03pm
424B2
urv1ote8f1
8 Mar 21
Prospectus for primary offering
5:00pm
6-K
EX-99.1
57n5su0bvuas dgm7qrz
4 Mar 21
Current report (foreign)
8:09am
6-K
EX-99.1
b87cwp53mgelj
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm
F-3
3icvr36rdk 94
24 Feb 21
Shelf registration (foreign)
5:22pm
8-A12B
84gm5kj2wj72ynal1
18 Feb 21
Registration of securities on exchange
12:46pm
6-K
EX-99.1
sa5nkd9d
1 Dec 20
Condensed Consolidated Interim Financial Statements
7:13am
6-K
EX-99.1
9iqkcrm9q08fine3
16 Oct 20
Consolidated Interim Financial Statements
2:44pm
6-K
EX-99.1
w5d3xsnw22a8v9fnr qb
13 Oct 20
Portage Issues Common Shares and Warrants In Settlement of Salvarx Loan Note Obligations
10:15am
6-K
6slh9bq jhzgfudbk
17 Jun 20
Report of Foreign Private Issuer
10:46am
6-K
rdp2 lw3rbg
26 May 20
Report of Foreign Private Issuer
5:19pm